The Valley Desk

NCT03134222 · Interventional trial

Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)

Overall registry status Completed

Phase 2

Conditions Cutaneous Lupus Erythematosus

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov